Literature DB >> 17022946

Characterization of the desensitization properties of five dopamine receptor subtypes and alternatively spliced variants of dopamine D2 and D4 receptors.

Dong-Im Cho1, SunRyeo Beom, Hubert H M Van Tol, Marc G Caron, Kyeong-Man Kim.   

Abstract

Proper regulation of brain dopaminergic activity is essential for maintaining normal mental functions. In this study, the regulatory properties of five different dopamine receptor subtypes and alternative splicing variants of dopamine D2 and D4 were examined. The stimulation of D1R, D2R, D5R but not D3R, D4R caused the robust translocation of beta-arrestin to the plasma membrane. When D1R or D3R were co-expressed with D2R, D1R significantly inhibited the sequestration of D2R, suggesting that the inhibitory effects of D1R on the D2R sequestration could explain the synergistic activity between two receptors. The sequestration of alternatively spliced isoforms of D2R was differently regulated by GRKs and beta-arrestins. Three alternative splicing variants of D4R produced a similar level of beta-arrestin translocation, and the studies with the deletion mutants of D4R within the third cytoplasmic loop revealed that the regions containing the SH3-binding domains are responsible for the beta-arrestin translocation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17022946     DOI: 10.1016/j.bbrc.2006.09.090

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

Review 1.  The dopamine D4 receptor: biochemical and signalling properties.

Authors:  Pieter Rondou; Guy Haegeman; Kathleen Van Craenenbroeck
Journal:  Cell Mol Life Sci       Date:  2010-02-18       Impact factor: 9.261

2.  Dopamine D(3) receptors are down-regulated following heterologous endocytosis by a specific interaction with G protein-coupled receptor-associated sorting protein-1.

Authors:  Dawn Thompson; Jennifer L Whistler
Journal:  J Biol Chem       Date:  2010-10-28       Impact factor: 5.157

3.  Dopamine D2 receptor relies upon PPM/PP2C protein phosphatases to dephosphorylate huntingtin protein.

Authors:  Sébastien Marion; Nikhil M Urs; Sean M Peterson; Tatyana D Sotnikova; Jean-Martin Beaulieu; Raul R Gainetdinov; Marc G Caron
Journal:  J Biol Chem       Date:  2014-03-11       Impact factor: 5.157

4.  Differential subcellular distribution of rat brain dopamine receptors and subtype-specific redistribution induced by cocaine.

Authors:  Pamela J Voulalas; John Schetz; Ashiwel S Undieh
Journal:  Mol Cell Neurosci       Date:  2011-01-12       Impact factor: 4.314

5.  An intracellular loop 2 amino acid residue determines differential binding of arrestin to the dopamine D2 and D3 receptors.

Authors:  Hongxiang Lan; Martha M Teeter; Vsevolod V Gurevich; Kim A Neve
Journal:  Mol Pharmacol       Date:  2008-09-26       Impact factor: 4.436

Review 6.  Alcoholism and alternative splicing of candidate genes.

Authors:  Toshikazu Sasabe; Shoichi Ishiura
Journal:  Int J Environ Res Public Health       Date:  2010-03-30       Impact factor: 3.390

7.  DISC1 regulates primary cilia that display specific dopamine receptors.

Authors:  Aaron Marley; Mark von Zastrow
Journal:  PLoS One       Date:  2010-05-28       Impact factor: 3.240

8.  Assortative human pair-bonding for partner ancestry and allelic variation of the dopamine receptor D4 (DRD4) gene.

Authors:  Dan T A Eisenberg; Coren L Apicella; Benjamin C Campbell; Anna Dreber; Justin R Garcia; J Koji Lum
Journal:  Soc Cogn Affect Neurosci       Date:  2009-08-27       Impact factor: 3.436

9.  Reversal of inhibition of putative dopaminergic neurons of the ventral tegmental area: interaction of GABA(B) and D2 receptors.

Authors:  S Nimitvilai; D S Arora; M A McElvain; M S Brodie
Journal:  Neuroscience       Date:  2012-09-15       Impact factor: 3.590

10.  Wild-type male offspring of fmr-1+/- mothers exhibit characteristics of the fragile X phenotype.

Authors:  Bojana Zupan; Miklos Toth
Journal:  Neuropsychopharmacology       Date:  2008-01-02       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.